Intranasal delivery bypasses the blood-brain barrier to target therapeutics to the brain to improve memory in humans with Alzheimer's and treat neurodegenerative disorders in animal models
Overview
authors
Frey II, William H., PhD
publication date
2007
Research
keywords
Alzheimer's Disease
Animal
Blood
Brain
Drugs
Intranasal Administration
Models
Therapy